314 related articles for article (PubMed ID: 16185681)
1. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance.
Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
Comput Biol Med; 2006; 36(7-8):748-67. PubMed ID: 16185681
[TBL] [Abstract][Full Text] [Related]
2. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach.
Bousquet C; Henegar C; Louët AL; Degoulet P; Jaulent MC
Int J Med Inform; 2005 Aug; 74(7-8):563-71. PubMed ID: 15955732
[TBL] [Abstract][Full Text] [Related]
3. A knowledge based approach for automated signal generation in pharmacovigilance.
Henegar C; Bousquet C; Lillo-Le Louët A; Degoulet P; Jaulent MC
Stud Health Technol Inform; 2004; 107(Pt 1):626-30. PubMed ID: 15360888
[TBL] [Abstract][Full Text] [Related]
4. Grouping pharmacovigilance terms with semantic distance.
Dupuch M; Lerch M; Jamet A; Jaulent MC; Fescharek R; Grabar N
Stud Health Technol Inform; 2011; 169():794-8. PubMed ID: 21893856
[TBL] [Abstract][Full Text] [Related]
5. Grouping the pharmacovigilance terms with a hybrid approach.
Dupuch M; Dupuch L; Perinet A; Hamon T; Grabar N
Stud Health Technol Inform; 2012; 180():235-9. PubMed ID: 22874187
[TBL] [Abstract][Full Text] [Related]
6. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
Inácio P; Airaksinen M; Cavaco A
Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
[TBL] [Abstract][Full Text] [Related]
7. Knowledge acquisition for computation of semantic distance between WHO-ART terms.
Iavindrasana J; Bousquet C; Jaulent MC
Stud Health Technol Inform; 2006; 124():839-44. PubMed ID: 17108617
[TBL] [Abstract][Full Text] [Related]
8. Automatic generation of MedDRA terms groupings using an ontology.
Declerck G; Bousquet C; Jaulent MC
Stud Health Technol Inform; 2012; 180():73-7. PubMed ID: 22874155
[TBL] [Abstract][Full Text] [Related]
9. Mapping of the WHO-ART terminology on Snomed CT to improve grouping of related adverse drug reactions.
Alecu I; Bousquet C; Mougin F; Jaulent MC
Stud Health Technol Inform; 2006; 124():833-8. PubMed ID: 17108616
[TBL] [Abstract][Full Text] [Related]
10. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
[TBL] [Abstract][Full Text] [Related]
11. National differences in reporting 'pneumonia' and 'pneumonia interstitial': an analysis of the WHO International Drug Monitoring Database on 15 drugs in nine countries for seven pulmonary conditions.
Koo LC; Clark JA; Quesenberry CP; Higenbottam T; Nyberg F; Wolf MK; Steinberg MH; Forsythe BH
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):775-87. PubMed ID: 15654720
[TBL] [Abstract][Full Text] [Related]
12. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation.
Dupuch M; Grabar N
J Biomed Inform; 2015 Apr; 54():174-85. PubMed ID: 25659451
[TBL] [Abstract][Full Text] [Related]
13. OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval.
Souvignet J; Declerck G; Asfari H; Jaulent MC; Bousquet C
J Biomed Inform; 2016 Oct; 63():100-107. PubMed ID: 27369567
[TBL] [Abstract][Full Text] [Related]
14. Modeling, building and evaluating an ontology for the automatic characterization of adverse drug effects during pharmacovigilance.
Duclos C; Soualmia LF; Krivine S; Jamet A; Lillo-Louët A
Stud Health Technol Inform; 2010; 160(Pt 2):1005-9. PubMed ID: 20841835
[TBL] [Abstract][Full Text] [Related]
15. The management of adverse drug reactions: from diagnosis to signal.
Edwards IR
Therapie; 2001; 56(6):727-33. PubMed ID: 11878098
[TBL] [Abstract][Full Text] [Related]
16. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
[TBL] [Abstract][Full Text] [Related]
17. [Organization and results of drug vigilance in France].
Bégaud B; Chaslerie A; Haramburu F
Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
[TBL] [Abstract][Full Text] [Related]
18. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
Durrieu G; Olivier P; Bagheri H; Montastruc JL;
Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
[TBL] [Abstract][Full Text] [Related]
19. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
[TBL] [Abstract][Full Text] [Related]
20. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
Mey C; Hentschel H; Hippius M; Balogh A
Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
